Women's Formula
Natural health product licensed in Canada
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80048118
- Status
- Active licence
- Licence date
- 5 February 2014
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Manganèse | 1.25 milligramme | 2,500 µg |
| Choline | 12.5 milligramme | Not calculated |
| Lutéine Source : Tagetes erecta - Fleur | 0.5 milligramme | Not calculated |
| Iode Source : Ascophyllum nodosum - whole | 75 microgrammes | Not calculated |
| Cuivre | 0.5 milligramme | 1,000 µg |
| Zinc | 7.5 milligramme | 15,000 µg |
Non-medicinal ingredients
Stéarate de magnésium, Jus de fruit de canneberge, Feuilles de Barbarea verna, Herbe d'orge, Saveur de feuille de Brassica oleracea var. capitata, Spirulina platensis extract, Capparis spinosa (Caperberry) fruit, Saveur de thé vert, Racine d'Eutrema japonica, Extrait de racine de radis, Feuilles d'Eruca sativa (Roquette), Glycérine, Extrait de fruit de Citrum Aurantium Dulcis (Oranger), Brassica Oleracea Italica (broccoli) Extract, Cilantro leaf, Poudre de Brassica oleracea var. botrytis (Chou-fleur), Lycopersicon Esculentum (Tomato) powder, Poudre de Aphanizomenon Flos-Aquae, Extrait de racine de zingiber officinale (Gingembre), Poudre de feuilles de caulet, Mélange de fruits, Graine de céleri en poudre, Microcrystalline cellulose, Curcumine, Carraghénine mi-raffinée, Kelp Extract, Concentré de jus de betterave, Croscarmellose de sodium, Acide stéarique, Groseillier de Ceylan, Chlorella Vulgaris biomass, Extrait de fruit d'euterpe oleracea, Dioxyde de silicium, Racines séchées de pissenlit, Carbohydrate gum, Feuille de cresson, Feuille de persil, Schisandra fruit
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Comprimé ; maximum: 2 Comprimé | minimum: 1 Tous les jours ; maximum: 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce the risk of neural tube defects when taken daily prior to becoming pregnant or during early pregnancy. Helps to form red blood cells. Helps the body to metabolize carbohydrates, fats and proteins. Helps normal growth and development. Helps in tissue formation. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in connective tissue formation. Helps in wound healing. An antioxidant for the maintenance of good health. Helps in the absorption and use of calcium and phosphorus. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise may reduce the risk of developing osteoporosis. Provides support for healthy glucose metabolism. Helps in the function of thyroid gland. Helps to maintain proper muscle function. Helps to maintain healthy skin and immune function. Source of vitamin A for the maintenance of good health. Source of vitamin A to help maintain eyesight, skin, membranes and immune function. Source of vitamin A to help in the development and maintenance of night vision.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80048118
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.